Aequs IPO Sees Strong Demand on Day One: Should You Invest?
Aequs Ltd’s initial public offering (IPO) has opened for subscription with a strong response on day one. Here’s what you need to know before investing.
Blog
Blog
Meesho IPO: Anchor Book Allocation Sparks Controversy Amidst High Demand
Meesho’s highly anticipated IPO has garnered significant attention, with its anchor book allotment sparking controversy due to higher allocation to SBI Mutual Fund. Learn more about the IPO and its implications for Indian investors.
Blog
Vodafone Idea AGR Relief: Cabinet Secretary Calls High-Level Meeting
Cabinet Secretary T.V. Somanathan has scheduled a meeting to deliberate on Vodafone Idea’s adjusted gross revenue dues and a fresh proposal for relief following the Supreme Court order.
Blog
GMR Airports Ltd. Initiates Coverage with 21% Upside Potential: BofA
Get the latest updates on GMR Airports Ltd. as BofA initiates coverage with a buy rating and a target price of Rs 128, implying 21% upside potential from current levels.
Blog
Time Technoplast: 44% Upside Potential Ahead, Says Motilal Oswal
Motilal Oswal reaffirms ‘Buy’ rating on Time Technoplast, citing robust growth prospects and attractive valuation. Get the latest updates on the Indian stock market and top stocks in focus.
Blog
JSW Steel Announces Rs 15,750 Crore JV With JFE Steel For BPSL: What Indian Investors Need To Know
JSW Steel Ltd. has announced a joint venture with Japan’s JFE Steel worth Rs 15,750 crore, involving the transfer of Bhushan Power and Steel’s integrated steel facility in Odisha to a 50:50 joint venture between the two companies.
Blog
NephroPlus IPO To Launch On Dec 10; To Raise Rs 353 Crore Via Fresh Issue
Nephrocare Health Services Ltd, known for its brand NephroPlus, is set to launch its initial public offering on Dec. 10, aiming to raise Rs 353.4 crore via a fresh issue of shares.
Blog
Rupee Depreciation Pressure To Ease In Q4: IDFC First Bank’s Gaura Sengupta
IDFC First Bank’s Chief Economist Gaura Sengupta expects the Indian rupee to see some relief in the fourth quarter as trade deficits narrow and flows from balance of payments improve.
Blog
2026 Will Be A Stock-Picker’s Market: Expert Insights for Indian Investors
Ace investor Porinju Veliyath shares his outlook for the Indian stock market in 2026, highlighting the importance of stock-specific opportunities and selective investing.
Blog
Corona Remedies IPO: Price Band Fixed, Issue to Open on Dec 8
Corona Remedies Ltd. has fixed its price band for the upcoming initial public offering, with the IPO set to open on Dec. 8. Here are the key details investors need to know.